beta

KERX

Keryx Biopharmaceuticals Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Keryx Biopharmaceuticals Inc acquires and develops novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Market Cap: 540 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.keryx.com

Shares Outstanding: 119 Million

Float: 112 Million

Dividend: 0.0 (0.0%)

Beta: 2.665747

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1270 trading days

From: 2014-08-29 To: 2018-12-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud